OnTarget aims to help pharmacists and other health care professionals counsel patients receiving
targeted therapies for the treatment of cancer and manage the adverse events that may occur.
This program was made possible due to the support of the GEOQ and to unrestricted grants provided by the
following pharmaceutical companies: AbbVie Corporation, Amgen Canada Inc., Astellas Pharma Canada, Astra Zeneca Canada,
Beigene, Ltd., Boehringer Ingelheim Canada Ltd., Bristol-Myers Squibb Canada Co., Eisai Limited, Eli Lilly Canada Inc.,
Gilead Sciences Canada Inc., GlaxoSmithKline, Hoffman-La Roche Ltd., Incyte Biosciences Canada, Janssen Inc.,
Merck Canada Inc., Novartis Pharmaceuticals Canada Inc., Paladin Lab inc., Pfizer Canada Inc., Sanofi Canada and
Takeda Canada Inc.